Home Shennon

Shennon

In operation
-
Immunotherapy Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Shenon Biotechnologies (ShenonBio) is a biotechnology company that uses a proprietary single-cell platform to create more effective immunotherapies. The company has developed a proprietary platform capable of functionally analyzing millions of immune cells at the single-cell level within a few hours, enabling the identification of TCR or antibody targets to develop more precise and effective immunotherapies.
Shennon Biotechnologies, Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2021
info@shennonbio.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Immunological Techniques
Concept
Tumor Immune System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs